{"transactions":[{"id":720812,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-29","kind":"exercise","planned":false,"acquired":false,"shares":215687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares underlying the option vested on January 19, 2025 and the remaining shares have vested or will vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":141313,"derivative":{"exercise_price":1.91,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":215687},"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720811,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":691832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720810,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":696832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720809,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":700832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720808,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":707832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720807,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-29","kind":"sale","planned":false,"acquired":false,"shares":215687,"price":4.09,"value":882159.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 to $4.14, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":721832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720806,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-29","kind":"exercise","planned":false,"acquired":true,"shares":215687,"price":1.91,"value":411962.17,"ownership":{"direct":true},"balance_after":937519,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":736090,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:24.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069250","document":"marketforms-73187.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390026069250/marketforms-73187.xml","form_type":"4"}},{"id":736257,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:21.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069249","document":"marketforms-73186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000121390026069249/marketforms-73186.xml","form_type":"4"}},{"id":735956,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":35382,"kind":"person","name":"Smith Cynthia","position":1,"cik":"0001609480","reported_name":"Smith Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:20.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069248","document":"marketforms-73185.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026069248/marketforms-73185.xml","form_type":"4"}},{"id":735992,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:18.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069247","document":"marketforms-73184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000121390026069247/marketforms-73184.xml","form_type":"4"}},{"id":736187,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:16.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069246","document":"marketforms-73183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000121390026069246/marketforms-73183.xml","form_type":"4"}},{"id":736085,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:15.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069245","document":"marketforms-73182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000121390026069245/marketforms-73182.xml","form_type":"4"}},{"id":735955,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37629,"kind":"person","name":"Flannelly Barry P","position":1,"cik":"0001615842","reported_name":"Flannelly Barry P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:13.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069244","document":"marketforms-73181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026069244/marketforms-73181.xml","form_type":"4"}},{"id":735985,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37635,"kind":"person","name":"BESHAR LUKE M","position":1,"cik":"0001192128","reported_name":"BESHAR LUKE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:08.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069243","document":"marketforms-73180.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192128/000121390026069243/marketforms-73180.xml","form_type":"4"}},{"id":751980,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T20:55:06.000Z","date":"2026-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6008,"price":4.34,"value":26074.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on June 2, 2025."}],"balance_after":69992,"source":{"system":"sec-edgar","filing":"0001213900-26-064792","document":"marketforms-73188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390026064792/marketforms-73188.xml","form_type":"4"}},{"id":811533,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-04-09T21:25:08.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":1134,"price":5.4,"value":6123.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025."}],"balance_after":94827,"source":{"system":"sec-edgar","filing":"0001213900-26-042079","document":"marketforms-72911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026042079/marketforms-72911.xml","form_type":"4"}},{"id":819735,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:05:11.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":22598,"price":5.26,"value":118865.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.31, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":95961,"source":{"system":"sec-edgar","filing":"0001213900-26-039328","document":"marketforms-72854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026039328/marketforms-72854.xml","form_type":"4"}},{"id":929848,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":68694,"kind":"person","name":"Fry Hannah","position":1,"cik":"0001938146","reported_name":"Fry Hannah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller"}}],"security":"Common Stock","published_at":"2026-01-27T21:10:15.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1457,"price":6.67,"value":9718.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025."}],"balance_after":42723,"source":{"system":"sec-edgar","filing":"0001213900-26-008222","document":"marketforms-71932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026008222/marketforms-71932.xml","form_type":"4"}},{"id":929977,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-27T21:10:13.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3261,"price":6.67,"value":21750.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025."}],"balance_after":64115,"source":{"system":"sec-edgar","filing":"0001213900-26-008221","document":"marketforms-71931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390026008221/marketforms-71931.xml","form_type":"4"}},{"id":929847,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-27T21:10:07.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":8732,"price":6.67,"value":58242.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025."}],"balance_after":1021832,"source":{"system":"sec-edgar","filing":"0001213900-26-008224","document":"marketforms-71934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026008224/marketforms-71934.xml","form_type":"4"}},{"id":930096,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2026-01-27T21:10:06.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3724,"price":6.67,"value":24839.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025."}],"balance_after":118559,"source":{"system":"sec-edgar","filing":"0001213900-26-008223","document":"marketforms-71933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026008223/marketforms-71933.xml","form_type":"4"}},{"id":933236,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-22T21:30:26.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":16322,"price":5.6,"value":91403.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":1030564,"source":{"system":"sec-edgar","filing":"0001213900-26-006711","document":"marketforms-71772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006711/marketforms-71772.xml","form_type":"4"}},{"id":933395,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-22T21:30:24.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3063,"price":5.6,"value":17152.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024."}],"balance_after":67376,"source":{"system":"sec-edgar","filing":"0001213900-26-006709","document":"marketforms-71771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390026006709/marketforms-71771.xml","form_type":"4"}},{"id":933450,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2026-01-22T21:30:23.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":6578,"price":5.6,"value":36836.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":122283,"source":{"system":"sec-edgar","filing":"0001213900-26-006708","document":"marketforms-71770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026006708/marketforms-71770.xml","form_type":"4"}},{"id":933237,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":68694,"kind":"person","name":"Fry Hannah","position":1,"cik":"0001938146","reported_name":"Fry Hannah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller"}}],"security":"Common Stock","published_at":"2026-01-22T21:30:21.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2132,"price":5.6,"value":11939.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":44180,"source":{"system":"sec-edgar","filing":"0001213900-26-006707","document":"marketforms-71769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006707/marketforms-71769.xml","form_type":"4"}},{"id":934355,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:37:27.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":158000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":158000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":158000},"source":{"system":"sec-edgar","filing":"0001213900-26-006231","document":"marketforms-71898.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390026006231/marketforms-71898.xml","form_type":"4"}},{"id":934354,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-21T21:37:27.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":76000,"source":{"system":"sec-edgar","filing":"0001213900-26-006231","document":"marketforms-71898.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390026006231/marketforms-71898.xml","form_type":"4"}},{"id":934209,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:37:07.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":175000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001213900-26-006230","document":"marketforms-71896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390026006230/marketforms-71896.xml","form_type":"4"}},{"id":934208,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-21T21:37:07.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":70439,"source":{"system":"sec-edgar","filing":"0001213900-26-006230","document":"marketforms-71896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390026006230/marketforms-71896.xml","form_type":"4"}},{"id":934057,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":68694,"kind":"person","name":"Fry Hannah","position":1,"cik":"0001938146","reported_name":"Fry Hannah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:36:51.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":55000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001213900-26-006229","document":"marketforms-71897.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006229/marketforms-71897.xml","form_type":"4"}},{"id":934056,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":68694,"kind":"person","name":"Fry Hannah","position":1,"cik":"0001938146","reported_name":"Fry Hannah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller"}}],"security":"Common Stock","published_at":"2026-01-21T21:36:51.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":46312,"source":{"system":"sec-edgar","filing":"0001213900-26-006229","document":"marketforms-71897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006229/marketforms-71897.xml","form_type":"4"}},{"id":934055,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":22773,"kind":"person","name":"Nicacio Leonardo Viana","position":1,"cik":"0002064901","reported_name":"Nicacio Leonardo Viana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:36:41.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":158000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":158000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":158000},"source":{"system":"sec-edgar","filing":"0001213900-26-006228","document":"marketforms-71899.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006228/marketforms-71899.xml","form_type":"4"}},{"id":934054,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":22773,"kind":"person","name":"Nicacio Leonardo Viana","position":1,"cik":"0002064901","reported_name":"Nicacio Leonardo Viana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-21T21:36:41.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":78181,"source":{"system":"sec-edgar","filing":"0001213900-26-006228","document":"marketforms-71899.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006228/marketforms-71899.xml","form_type":"4"}},{"id":934051,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:36:25.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":524000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":524000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":524000},"source":{"system":"sec-edgar","filing":"0001213900-26-006226","document":"marketforms-71894.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006226/marketforms-71894.xml","form_type":"4"}},{"id":934050,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-21T21:36:25.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":1046886,"source":{"system":"sec-edgar","filing":"0001213900-26-006226","document":"marketforms-71894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006226/marketforms-71894.xml","form_type":"4"}},{"id":934325,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:36:09.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":180000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001213900-26-006225","document":"marketforms-71895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026006225/marketforms-71895.xml","form_type":"4"}},{"id":934324,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2026-01-21T21:36:09.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":128861,"source":{"system":"sec-edgar","filing":"0001213900-26-006225","document":"marketforms-71895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026006225/marketforms-71895.xml","form_type":"4"}},{"id":1091175,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-07-07T20:10:10.000Z","date":"2025-06-24","kind":"gift","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On June 24, 2025, the reporting person transferred 300,000 shares of common stock to The Samhold Family Trust for no consideration. Members of the reporting person's immediate family are the sole beneficiaries of the trust and a member of the reporting person's immediate family serves as a trustee thereof. The reporting person remains the beneficial owner of the securities held by the trust."}],"balance_after":659886,"source":{"system":"sec-edgar","filing":"0001213900-25-061772","document":"marketforms-70060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025061772/marketforms-70060.xml","form_type":"4"}},{"id":1099096,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-30T20:10:10.000Z","date":"2025-06-27","kind":"gift","planned":false,"acquired":false,"shares":3367,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":959886,"source":{"system":"sec-edgar","filing":"0001213900-25-059655","document":"marketforms-69999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025059655/marketforms-69999.xml","form_type":"4"}},{"id":1099095,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-30T20:10:10.000Z","date":"2025-06-27","kind":"gift","planned":false,"acquired":false,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":963253,"source":{"system":"sec-edgar","filing":"0001213900-25-059655","document":"marketforms-69999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025059655/marketforms-69999.xml","form_type":"4"}},{"id":1099094,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-30T20:10:10.000Z","date":"2025-06-26","kind":"gift","planned":false,"acquired":false,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":973453,"source":{"system":"sec-edgar","filing":"0001213900-25-059655","document":"marketforms-69999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025059655/marketforms-69999.xml","form_type":"4"}},{"id":1099093,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-30T20:10:10.000Z","date":"2025-06-26","kind":"gift","planned":false,"acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":976853,"source":{"system":"sec-edgar","filing":"0001213900-25-059655","document":"marketforms-69999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025059655/marketforms-69999.xml","form_type":"4"}},{"id":1111291,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:27.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054286","document":"marketforms-69816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000121390025054286/marketforms-69816.xml","form_type":"4"}},{"id":1111494,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:20.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054285","document":"marketforms-69815.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390025054285/marketforms-69815.xml","form_type":"4"}},{"id":1111782,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:13.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054288","document":"marketforms-69818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000121390025054288/marketforms-69818.xml","form_type":"4"}},{"id":1111666,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:12.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054284","document":"marketforms-69814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000121390025054284/marketforms-69814.xml","form_type":"4"}},{"id":1111489,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:11.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054283","document":"marketforms-69813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000121390025054283/marketforms-69813.xml","form_type":"4"}},{"id":1111187,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":35382,"kind":"person","name":"Smith Cynthia","position":1,"cik":"0001609480","reported_name":"Smith Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:11.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054287","document":"marketforms-69817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025054287/marketforms-69817.xml","form_type":"4"}},{"id":1111186,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37629,"kind":"person","name":"Flannelly Barry P","position":1,"cik":"0001615842","reported_name":"Flannelly Barry P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:10.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054282","document":"marketforms-69812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025054282/marketforms-69812.xml","form_type":"4"}},{"id":1111280,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37635,"kind":"person","name":"BESHAR LUKE M","position":1,"cik":"0001192128","reported_name":"BESHAR LUKE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:06.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054280","document":"marketforms-69807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192128/000121390025054280/marketforms-69807.xml","form_type":"4"}},{"id":1123109,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-04T20:10:26.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of June 2, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":200000,"derivative":{"exercise_price":3.3,"expiration_date":"2035-06-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-25-051157","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390025051157/ownership.xml","form_type":"4"}},{"id":1123108,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T20:10:26.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of June 2, 2025."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001213900-25-051157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390025051157/ownership.xml","form_type":"4"}},{"id":1142554,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:10:10.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.19,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":51000,"source":{"system":"sec-edgar","filing":"0001213900-25-045399","document":"marketforms-69540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390025045399/marketforms-69540.xml","form_type":"4/A","original_submission_date":"2025-05-16"}},{"id":1145217,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":26662,"kind":"person","name":"Levy Richard S","position":1,"cik":"0001454983","reported_name":"Levy Richard S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:05:07.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.19,"value":63800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":51000,"source":{"system":"sec-edgar","filing":"0001213900-25-044871","document":"marketforms-69472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454983/000121390025044871/marketforms-69472.xml","form_type":"4"}},{"id":1169509,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":22773,"kind":"person","name":"Nicacio Leonardo Viana","position":1,"cik":"0002064901","reported_name":"Nicacio Leonardo Viana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-17T20:10:28.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of April 15, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":150000,"derivative":{"exercise_price":4.17,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-25-032965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025032965/ownership.xml","form_type":"4"}},{"id":1169508,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":22773,"kind":"person","name":"Nicacio Leonardo Viana","position":1,"cik":"0002064901","reported_name":"Nicacio Leonardo Viana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-17T20:10:28.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of April 15, 2025."}],"balance_after":52181,"source":{"system":"sec-edgar","filing":"0001213900-25-032965","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025032965/ownership.xml","form_type":"4"}},{"id":1188881,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2025-03-28T20:12:14.000Z","date":"2025-03-26","kind":"sale","planned":true,"acquired":false,"shares":21224,"price":4.53,"value":96144.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.69, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":98861,"source":{"system":"sec-edgar","filing":"0001013762-25-004101","document":"marketforms-68923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000101376225004101/marketforms-68923.xml","form_type":"4"}},{"id":1292875,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T21:05:17.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":387000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":387000,"derivative":{"exercise_price":4.53,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":387000},"source":{"system":"sec-edgar","filing":"0001213900-25-007533","document":"marketforms-67930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025007533/marketforms-67930.xml","form_type":"4"}},{"id":1292874,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-01-28T21:05:17.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025."}],"balance_after":994022,"source":{"system":"sec-edgar","filing":"0001213900-25-007533","document":"marketforms-67930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025007533/marketforms-67930.xml","form_type":"4"}},{"id":1293115,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T21:05:15.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":146000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":146000,"derivative":{"exercise_price":4.53,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":146000},"source":{"system":"sec-edgar","filing":"0001213900-25-007532","document":"marketforms-67931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390025007532/marketforms-67931.xml","form_type":"4"}},{"id":1293114,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2025-01-28T21:05:15.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025."}],"balance_after":126639,"source":{"system":"sec-edgar","filing":"0001213900-25-007532","document":"marketforms-67931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390025007532/marketforms-67931.xml","form_type":"4"}},{"id":1292873,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":68694,"kind":"person","name":"Fry Hannah","position":1,"cik":"0001938146","reported_name":"Fry Hannah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T21:05:14.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":55000,"derivative":{"exercise_price":4.53,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001213900-25-007531","document":"marketforms-67929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025007531/marketforms-67929.xml","form_type":"4"}},{"id":1292872,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":68694,"kind":"person","name":"Fry Hannah","position":1,"cik":"0001938146","reported_name":"Fry Hannah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller"}}],"security":"Common Stock","published_at":"2025-01-28T21:05:14.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025."}],"balance_after":38942,"source":{"system":"sec-edgar","filing":"0001213900-25-007531","document":"marketforms-67929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025007531/marketforms-67929.xml","form_type":"4"}},{"id":1293043,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T21:05:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":140000,"derivative":{"exercise_price":4.53,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001213900-25-007530","document":"marketforms-67928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390025007530/marketforms-67928.xml","form_type":"4"}},{"id":1293042,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-28T21:05:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025."}],"balance_after":45500,"source":{"system":"sec-edgar","filing":"0001213900-25-007530","document":"marketforms-67928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390025007530/marketforms-67928.xml","form_type":"4"}},{"id":1296242,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-01-23T21:05:19.000Z","date":"2025-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":15469,"price":4.76,"value":73632.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":913553,"source":{"system":"sec-edgar","filing":"0001213900-25-005962","document":"marketforms-67893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025005962/marketforms-67893.xml","form_type":"4"}},{"id":1296366,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-23T21:05:14.000Z","date":"2025-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":3061,"price":4.76,"value":14570.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024."}],"balance_after":18939,"source":{"system":"sec-edgar","filing":"0001213900-25-005966","document":"marketforms-67896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390025005966/marketforms-67896.xml","form_type":"4"}},{"id":1296241,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":68694,"kind":"person","name":"Fry Hannah","position":1,"cik":"0001938146","reported_name":"Fry Hannah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller"}}],"security":"Common Stock","published_at":"2025-01-23T21:05:12.000Z","date":"2025-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":2130,"price":4.76,"value":10138.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":27312,"source":{"system":"sec-edgar","filing":"0001213900-25-005964","document":"marketforms-67895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025005964/marketforms-67895.xml","form_type":"4"}},{"id":1296445,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2025-01-23T21:05:11.000Z","date":"2025-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":6554,"price":4.76,"value":31197.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":95585,"source":{"system":"sec-edgar","filing":"0001213900-25-005963","document":"marketforms-67894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390025005963/marketforms-67894.xml","form_type":"4"}},{"id":1307661,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-01-07T21:20:13.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6479,"price":6.14,"value":39781.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":929022,"source":{"system":"sec-edgar","filing":"0001213900-25-001648","document":"marketforms-67735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025001648/marketforms-67735.xml","form_type":"4"}},{"id":1308171,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2025-01-07T21:20:12.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2157,"price":6.14,"value":13243.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":102139,"source":{"system":"sec-edgar","filing":"0001213900-25-001646","document":"marketforms-67734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390025001646/marketforms-67734.xml","form_type":"4"}},{"id":1307660,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":68694,"kind":"person","name":"Fry Hannah","position":1,"cik":"0001938146","reported_name":"Fry Hannah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller"}}],"security":"Common Stock","published_at":"2025-01-07T21:20:09.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":394,"price":6.14,"value":2419.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":29442,"source":{"system":"sec-edgar","filing":"0001213900-25-001645","document":"marketforms-67733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025001645/marketforms-67733.xml","form_type":"4"}},{"id":1408444,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-09-13T00:20:11.000Z","date":"2024-09-12","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":1.7089,"value":11107.85,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70-$1.75 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001493152-24-036106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224036106/ownership.xml","form_type":"4"}},{"id":1408443,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-09-13T00:20:11.000Z","date":"2024-09-12","kind":"sale","planned":false,"acquired":false,"shares":119801,"price":1.7089,"value":204727.9289,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70-$1.75 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":1944134,"source":{"system":"sec-edgar","filing":"0001493152-24-036106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224036106/ownership.xml","form_type":"4"}},{"id":1408442,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-09-13T00:20:11.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":1600,"price":1.7141,"value":2742.56,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70-$1.74 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":51500,"source":{"system":"sec-edgar","filing":"0001493152-24-036106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224036106/ownership.xml","form_type":"4"}},{"id":1408441,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-09-13T00:20:11.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":31000,"price":1.7141,"value":53137.1,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70-$1.74 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2063935,"source":{"system":"sec-edgar","filing":"0001493152-24-036106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224036106/ownership.xml","form_type":"4"}},{"id":1410659,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-09-10T23:11:02.000Z","date":"2024-09-10","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":1.769,"value":2653.5,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69-$1.81 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":53100,"source":{"system":"sec-edgar","filing":"0001493152-24-035684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224035684/ownership.xml","form_type":"4"}},{"id":1410658,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-09-10T23:11:02.000Z","date":"2024-09-10","kind":"sale","planned":false,"acquired":false,"shares":24000,"price":1.769,"value":42456.0,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69-$1.81 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2094935,"source":{"system":"sec-edgar","filing":"0001493152-24-035684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224035684/ownership.xml","form_type":"4"}},{"id":1410657,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-09-10T23:11:02.000Z","date":"2024-09-09","kind":"sale","planned":false,"acquired":false,"shares":1900,"price":1.8947,"value":3599.93,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.84-$1.9566 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":54600,"source":{"system":"sec-edgar","filing":"0001493152-24-035684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224035684/ownership.xml","form_type":"4"}},{"id":1410656,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-09-10T23:11:02.000Z","date":"2024-09-09","kind":"sale","planned":false,"acquired":false,"shares":34592,"price":1.8947,"value":65541.4624,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.84-$1.9566 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2118935,"source":{"system":"sec-edgar","filing":"0001493152-24-035684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224035684/ownership.xml","form_type":"4"}},{"id":1418846,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-30T20:05:11.000Z","date":"2024-08-28","kind":"gift","planned":false,"acquired":false,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":935501,"source":{"system":"sec-edgar","filing":"0001213900-24-074514","document":"marketforms-66787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024074514/marketforms-66787.xml","form_type":"4"}},{"id":1418845,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-30T20:05:11.000Z","date":"2024-08-28","kind":"gift","planned":false,"acquired":false,"shares":5263,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":938801,"source":{"system":"sec-edgar","filing":"0001213900-24-074514","document":"marketforms-66787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024074514/marketforms-66787.xml","form_type":"4"}},{"id":1451704,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-18T20:05:10.000Z","date":"2024-07-16","kind":"sale","planned":false,"acquired":false,"shares":3500,"price":2.4419,"value":8546.65,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4397-$2.5125 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":56500,"source":{"system":"sec-edgar","filing":"0001493152-24-028330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224028330/ownership.xml","form_type":"4"}},{"id":1451703,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-18T20:05:10.000Z","date":"2024-07-16","kind":"sale","planned":false,"acquired":false,"shares":7896,"price":2.4419,"value":19281.2424,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4397-$2.5125 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2153527,"source":{"system":"sec-edgar","filing":"0001493152-24-028330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224028330/ownership.xml","form_type":"4"}},{"id":1455882,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-11T23:56:13.000Z","date":"2024-07-11","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":2.4034,"value":36051.0,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.3688-$2.4602 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001493152-24-027028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224027028/ownership.xml","form_type":"4"}},{"id":1455881,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-11T23:56:13.000Z","date":"2024-07-11","kind":"sale","planned":false,"acquired":false,"shares":32993,"price":2.4034,"value":79295.3762,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.3688-$2.4602 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2161423,"source":{"system":"sec-edgar","filing":"0001493152-24-027028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224027028/ownership.xml","form_type":"4"}},{"id":1455880,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-11T23:56:13.000Z","date":"2024-07-10","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":2.308,"value":11540.0,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20-$2.313 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001493152-24-027028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224027028/ownership.xml","form_type":"4"}},{"id":1455879,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-11T23:56:13.000Z","date":"2024-07-10","kind":"sale","planned":false,"acquired":false,"shares":13061,"price":2.308,"value":30144.788,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20-$2.313 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2194416,"source":{"system":"sec-edgar","filing":"0001493152-24-027028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224027028/ownership.xml","form_type":"4"}},{"id":1455878,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-11T23:56:13.000Z","date":"2024-07-09","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":2.2138,"value":5534.5,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.2128-$2.25 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001493152-24-027028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224027028/ownership.xml","form_type":"4"}},{"id":1455877,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-11T23:56:13.000Z","date":"2024-07-09","kind":"sale","planned":false,"acquired":false,"shares":5997,"price":2.2138,"value":13276.1586,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.2128-$2.25 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2207477,"source":{"system":"sec-edgar","filing":"0001493152-24-027028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224027028/ownership.xml","form_type":"4"}},{"id":1459543,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-03T18:00:08.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":2.1233,"value":5308.25,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.1021-$2.1611 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001493152-24-026181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224026181/ownership.xml","form_type":"4"}},{"id":1459542,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-07-03T18:00:08.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":5788,"price":2.1233,"value":12289.6604,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.1021-$2.1611 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2213474,"source":{"system":"sec-edgar","filing":"0001493152-24-026181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224026181/ownership.xml","form_type":"4"}},{"id":1467054,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-06-28T22:45:05.000Z","date":"2024-06-28","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":2.0748,"value":10374.0,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.05-$2.26 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001493152-24-025666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224025666/ownership.xml","form_type":"4"}},{"id":1467053,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-06-28T22:45:05.000Z","date":"2024-06-28","kind":"sale","planned":false,"acquired":false,"shares":12994,"price":2.0748,"value":26959.9512,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.05-$2.26 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2219262,"source":{"system":"sec-edgar","filing":"0001493152-24-025666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224025666/ownership.xml","form_type":"4"}},{"id":1467052,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-06-28T22:45:05.000Z","date":"2024-06-27","kind":"sale","planned":false,"acquired":false,"shares":12471,"price":2.2581,"value":28160.7651,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10-$2.25 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001493152-24-025666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224025666/ownership.xml","form_type":"4"}},{"id":1467051,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-06-28T22:45:05.000Z","date":"2024-06-27","kind":"sale","planned":false,"acquired":false,"shares":34103,"price":2.2581,"value":77007.9843,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10-$2.25 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2232256,"source":{"system":"sec-edgar","filing":"0001493152-24-025666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224025666/ownership.xml","form_type":"4"}},{"id":1467994,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-06-27T20:05:33.000Z","date":"2024-06-25","kind":"sale","planned":false,"acquired":false,"shares":6225,"price":2.2581,"value":14056.6725,"ownership":{"direct":false,"nature":"By Managed account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25-$2.26 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned by a separately managed account (the \"Managed Account\"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account."}],"balance_after":102471,"source":{"system":"sec-edgar","filing":"0001493152-24-025428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224025428/ownership.xml","form_type":"4"}},{"id":1467993,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":1559,"kind":"organization","name":"Opaleye Management Inc.","position":1,"cik":"0001595855","reported_name":"Opaleye Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-06-27T20:05:33.000Z","date":"2024-06-25","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":2.2581,"value":14677.65,"ownership":{"direct":false,"nature":"By Opaleye, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25-$2.26 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund."}],"balance_after":2266359,"source":{"system":"sec-edgar","filing":"0001493152-24-025428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000149315224025428/ownership.xml","form_type":"4"}},{"id":1484590,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37629,"kind":"person","name":"Flannelly Barry P","position":1,"cik":"0001615842","reported_name":"Flannelly Barry P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T22:00:31.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.67,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-24-051382","document":"marketforms-66265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024051382/marketforms-66265.xml","form_type":"4"}}],"next_cursor":"2024-06-10T22:00:31.000000Z,1484590"}